Opioid-sparing effects of medical cannabis or cannabinoids for chronic pain: a systematic review and meta-analysis of randomised and observational studies

A Noori, A Miroshnychenko, Y Shergill, V Ashoorion… - BMJ open, 2021 - bmjopen.bmj.com
Objective To assess the efficacy and harms of adding medical cannabis to prescription
opioids among people living with chronic pain. Design Systematic review. Data sources …

[HTML][HTML] Medical cannabis for the reduction of opioid dosage in the treatment of non-cancer chronic pain: a systematic review

BO Okusanya, IO Asaolu, JE Ehiri, LJ Kimaru… - Systematic reviews, 2020 - Springer
Background Medical cannabis (MC) is currently being used as an adjunct to opiates given
its analgesic effects and potential to reduce opiate addiction. This review assessed if MC …

Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials

L Wang, PJ Hong, C May, Y Rehman, Y Oparin… - Bmj, 2021 - bmj.com
Objective To determine the benefits and harms of medical cannabis and cannabinoids for
chronic pain. Design Systematic review and meta-analysis. Data sources MEDLINE …

[HTML][HTML] Practical strategies using medical cannabis to reduce harms associated with long term opioid use in chronic pain

CA MacCallum, L Eadie, AM Barr, M Boivin… - Frontiers in …, 2021 - frontiersin.org
Background: Chronic non-cancer pain (CNCP) is estimated to affect 20% of the adult
population. Current United States and Canadian Chronic non-cancer pain guidelines …

[HTML][HTML] Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study

G Campbell, WD Hall, A Peacock, N Lintzeris… - The Lancet Public …, 2018 - thelancet.com
Background Interest in the use of cannabis and cannabinoids to treat chronic non-cancer
pain is increasing, because of their potential to reduce opioid dose requirements. We aimed …

Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational …

E Stockings, G Campbell, WD Hall, S Nielsen, D Zagic… - Pain, 2018 - journals.lww.com
This review examines evidence for the effectiveness of cannabinoids in chronic noncancer
pain (CNCP) and addresses gaps in the literature by: considering differences in outcomes …

Efficacy, tolerability and safety of cannabis-based medicines for cancer pain: A systematic review with meta-analysis of randomised controlled trials.

W Haeuser, P Welsch, P Klose, L Radbruch… - Schmerz (Berlin …, 2019 - europepmc.org
Background The importance of medical cannabis and cannabis-based medicines for cancer
pain management needs to be determined. Methods A systematic literature search until …

The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: A systematic review and network meta-analysis

K Rabgay, N Waranuch, N Chaiyakunapruk… - Journal of the American …, 2020 - Elsevier
Objectives To determine the effects of cannabis, cannabinoids, and their administration
routes on pain and adverse euphoria events. Data sources A systematic search was …

Long-term and serious harms of medical cannabis and cannabinoids for chronic pain: A systematic review of non-randomised studies

D Zeraatkar, MA Cooper, A Agarwal, RWM Vernooij… - BMJ open, 2022 - bmjopen.bmj.com
Objective To establish the prevalence of long-term and serious harms of medical cannabis
for chronic pain. Design Systematic review and meta-analysis. Data sources MEDLINE …

[HTML][HTML] Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain

KF Boehnke, E Litinas, DJ Clauw - The Journal of Pain, 2016 - Elsevier
Opioids are commonly used to treat patients with chronic pain (CP), though there is little
evidence that they are effective for long term CP treatment. Previous studies reported strong …